| Abstrakt: |
A recent study conducted by researchers at the University of Madras in Tamil Nadu, India, has yielded new findings on anticancer agents. The researchers synthesized a new curcumin derivative and examined its structure, molecular interactions, and anticancer activity. The compound showed high toxicity against HEK293 cell lines and demonstrated efficacy as an anticancer agent in MCF-7 cell lines. Molecular docking simulations indicated that the compound could be a potential drug candidate. Further biological and pharmaceutical investigations are needed to confirm its suitability as a drug. [Extracted from the article] |
